Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus.

× No keyword cloud information.

18 in total

1. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease.

Authors: Vincent Ries; Claire Henchcliffe; Tatyana Kareva; Margarita Rzhetskaya; Ross Bland; Matthew J During; Nikolai Kholodilov; Robert E Burke
Journal: Proc Natl Acad Sci U S A Date: 2006-11-20 Impact factor: 11.205

Review 2. Mitochondrial mechanisms of redox cycling agents implicated in Parkinson's disease.

Authors: Pamela Lopert; Manisha Patel
Journal: J Neural Transm (Vienna) Date: 2015-03-07 Impact factor: 3.575

3. Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment.

Authors: Phumzile Nomfundo Ngema; Musa Vuyisile Mabandla
Journal: Metab Brain Dis Date: 2017-03-20 Impact factor: 3.584

4. Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans.

Authors: Richard Nass; David H Hall; David M Miller; Randy D Blakely
Journal: Proc Natl Acad Sci U S A Date: 2002-02-26 Impact factor: 11.205

Review 5. A guide to neurotoxic animal models of Parkinson's disease.

Authors: Kim Tieu
Journal: Cold Spring Harb Perspect Med Date: 2011-09 Impact factor: 6.915

6. The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells.

Authors: Victoria Tarabin; Markus Schwaninger
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2004-05-13 Impact factor: 3.000

Review 7. Mitochondrial control of cell bioenergetics in Parkinson's disease.

Authors: Raquel Requejo-Aguilar; Juan P Bolaños
Journal: Free Radic Biol Med Date: 2016-04-16 Impact factor: 7.376

8. GTP cyclohydrolase I deficiency, a new enzyme defect causing hyperphenylalaninemia with neopterin, biopterin, dopamine, and serotonin deficiencies and muscular hypotonia.

Authors: A Niederwieser; N Blau; M Wang; P Joller; M Atarés; J Cardesa-Garcia
Journal: Eur J Pediatr Date: 1984-02 Impact factor: 3.183

9. The determination of hydroxydopamines and other trace amines in the urine of parkinsonian patients and normal controls.

Authors: R Andrew; D G Watson; S A Best; J M Midgley; H Wenlong; R K Petty
Journal: Neurochem Res Date: 1993-11 Impact factor: 3.996

Review 10. Proteomic approach to studying Parkinson's disease.

Authors: Jing Zhang; David R Goodlett
Journal: Mol Neurobiol Date: 2004-06 Impact factor: 5.590